Genome	O
-	O
wide	O
approaches	O
reveal	O
functional	O
interleukin	B-GENE
-	I-GENE
4	E-GENE
-	O
inducible	O
STAT6	S-GENE
binding	O
to	O
the	O
vascular	B-GENE
cell	I-GENE
adhesion	I-GENE
molecule	I-GENE
1	E-GENE
promoter	O
.	O


Endothelial	O
cell	O
activation	O
and	O
dysfunction	O
underlie	O
many	O
vascular	O
disorders	O
,	O
including	O
atherosclerosis	O
and	O
inflammation	O
.	O


Here	O
,	O
we	O
show	O
that	O
interleukin	B-GENE
-	I-GENE
4	E-GENE
(	O
IL	B-GENE
-	I-GENE
4	E-GENE
)	O
markedly	O
induced	O
vascular	B-GENE
cell	I-GENE
adhesion	I-GENE
molecule	I-GENE
1	E-GENE
(	O
VCAM	B-GENE
-	I-GENE
1	E-GENE
)	O
,	O
both	O
in	O
cultured	O
endothelial	O
cells	O
and	O
in	O
the	O
intact	O
endothelium	O
in	O
mice	O
.	O


Combined	O
treatment	O
with	O
IL	B-GENE
-	I-GENE
4	E-GENE
and	O
tumor	B-GENE
necrosis	I-GENE
factor	I-GENE
alpha	E-GENE
(	O
TNF	B-GENE
-	I-GENE
alpha	E-GENE
)	O
resulted	O
in	O
further	O
,	O
sustained	O
induction	O
of	O
VCAM	B-GENE
-	I-GENE
1	E-GENE
expression	O
.	O
IL	B-GENE
-	I-GENE
4	E-GENE
-	O
mediated	O
induction	O
of	O
VCAM	B-GENE
-	I-GENE
1	E-GENE
and	O
secondary	O
monocyte	O
adhesion	O
was	O
predominantly	O
regulated	O
by	O
the	O
transcription	O
factor	O
STAT6	S-GENE
.	O


Genome	O
-	O
wide	O
survey	O
of	O
IL	B-GENE
-	I-GENE
4	E-GENE
-	O
mediated	O
STAT6	S-GENE
binding	O
from	O
sequential	O
chromatin	O
-	O
immunoprecipitation	O
with	O
deep	O
sequencing	O
(	O
chromatin	O
immunoprecipitation	O
sequencing	O
[	O
ChIP	O
-	O
seq	O
]	O
)	O
in	O
endothelial	O
cells	O
revealed	O
regions	O
of	O
transient	O
and	O
sustained	O
transcription	O
factor	O
binding	O
.	O


Through	O
the	O
combination	O
of	O
DNA	O
microarrays	O
and	O
ChIP	O
-	O
seq	O
at	O
the	O
same	O
time	O
points	O
,	O
the	O
majority	O
of	O
IL	B-GENE
-	I-GENE
4	E-GENE
-	O
responsive	O
genes	O
were	O
shown	O
to	O
be	O
STAT6	S-GENE
dependent	O
and	O
associated	O
with	O
direct	O
STAT6	S-GENE
binding	O
to	O
their	O
promoter	O
.	O
IL	B-GENE
-	I-GENE
4	E-GENE
-	O
mediated	O
stable	O
binding	O
of	O
STAT6	S-GENE
led	O
to	O
sustained	O
target	O
gene	O
expression	O
.	O


Moreover	O
,	O
our	O
strategy	O
led	O
to	O
the	O
identification	O
of	O
a	O
novel	O
functionally	O
important	O
STAT6	S-GENE
binding	O
site	O
within	O
16	O
kb	O
upstream	O
of	O
the	O
VCAM	B-GENE
-	I-GENE
1	E-GENE
gene	O
.	O


Taken	O
together	O
,	O
these	O
findings	O
support	O
a	O
critical	O
role	O
for	O
STAT6	S-GENE
in	O
mediating	O
IL	B-GENE
-	I-GENE
4	E-GENE
signal	O
transduction	O
in	O
endothelial	O
cells	O
.	O


Identification	O
of	O
a	O
novel	O
IL	B-GENE
-	I-GENE
4	E-GENE
-	O
mediated	O
VCAM	B-GENE
-	I-GENE
1	E-GENE
enhancer	O
may	O
provide	O
a	O
foundation	O
for	O
targeted	O
therapy	O
in	O
vascular	O
disease	O
.	O
